Free Trial

Jin Medical International (ZJYL) Competitors

→ The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad)
Free ZJYL Stock Alerts
$4.04
+0.12 (+3.06%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media

ZJYL vs. SMTI, AVNS, INGN, ESTA, OABI, INNV, KRRO, VALN, CALT, and ALT

Should you be buying Jin Medical International stock or one of its competitors? The main competitors of Jin Medical International include Sanara MedTech (SMTI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), OmniAb (OABI), InnovAge (INNV), Korro Bio (KRRO), Valneva (VALN), Calliditas Therapeutics AB (publ) (CALT), and Altimmune (ALT). These companies are all part of the "medical" sector.

Jin Medical International vs.

Sanara MedTech (NASDAQ:SMTI) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, community ranking, earnings, profitability, dividends, media sentiment and analyst recommendations.

Sanara MedTech received 17 more outperform votes than Jin Medical International when rated by MarketBeat users.

CompanyUnderperformOutperform
Sanara MedTechOutperform Votes
17
53.13%
Underperform Votes
15
46.88%
Jin Medical InternationalN/AN/A

Jin Medical International has lower revenue, but higher earnings than Sanara MedTech.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanara MedTech$64.99M4.29-$4.30M-$0.52-62.21
Jin Medical InternationalN/AN/AN/AN/AN/A

8.1% of Sanara MedTech shares are owned by institutional investors. 55.2% of Sanara MedTech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Jin Medical International has a net margin of 0.00% compared to Jin Medical International's net margin of -6.62%. Sanara MedTech's return on equity of 0.00% beat Jin Medical International's return on equity.

Company Net Margins Return on Equity Return on Assets
Sanara MedTech-6.62% -11.12% -7.11%
Jin Medical International N/A N/A N/A

In the previous week, Sanara MedTech and Sanara MedTech both had 2 articles in the media. Sanara MedTech's average media sentiment score of 0.34 beat Jin Medical International's score of -0.36 indicating that Jin Medical International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sanara MedTech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Jin Medical International
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sanara MedTech currently has a consensus target price of $44.00, indicating a potential upside of 36.01%. Given Jin Medical International's higher possible upside, research analysts plainly believe Sanara MedTech is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanara MedTech
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Jin Medical International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Sanara MedTech beats Jin Medical International on 6 of the 10 factors compared between the two stocks.

Get Jin Medical International News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZJYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZJYL vs. The Competition

Export to Excel
MetricJin Medical InternationalSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$626.20M$8.77B$4.88B$7.55B
Dividend YieldN/A1.40%2.91%3.95%
P/E RatioN/A26.92232.4819.19
Price / SalesN/A54.942,338.7085.76
Price / CashN/A20.5047.0434.73
Price / BookN/A5.754.764.33
Net IncomeN/A$174.69M$103.54M$214.22M
7 Day Performance4.39%0.41%0.74%1.88%
1 Month Performance5.21%-7.38%-7.60%-5.23%
1 Year Performance-47.05%-13.34%9.25%8.41%

Jin Medical International Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMTI
Sanara MedTech
1.1261 of 5 stars		$32.60
-0.9%		$44.00
+35.0%		-23.0%$281.01M$64.99M-62.69107
AVNS
Avanos Medical
3.7645 of 5 stars		$18.76
-1.0%		$31.00
+65.2%		-39.2%$866.71M$673.30M-14.213,771Upcoming Earnings
News Coverage
Positive News
INGN
Inogen
2.6506 of 5 stars		$6.90
+3.0%		$7.50
+8.7%		-48.2%$162.50M$315.66M-1.56834Short Interest ↑
ESTA
Establishment Labs
1.063 of 5 stars		$49.69
+2.9%		$55.00
+10.7%		-29.2%$1.36B$165.15M-16.35908News Coverage
OABI
OmniAb
2.6397 of 5 stars		$4.64
-0.9%		$9.00
+94.0%		+28.7%$543.47M$34.16M-9.10106
INNV
InnovAge
0.8549 of 5 stars		$4.00
-0.7%		$6.50
+62.5%		N/A$543.60M$688.09M-16.002,100News Coverage
KRRO
Korro Bio
2.2505 of 5 stars		$67.94
-0.6%		$126.25
+85.8%		N/A$544.88M$14.07M-0.7295Insider Buying
Short Interest ↑
Gap Down
High Trading Volume
VALN
Valneva
1.1906 of 5 stars		$7.74
-2.3%		$21.67
+179.8%		-19.7%$539.20M$165.52M-4.90676Upcoming Earnings
CALT
Calliditas Therapeutics AB (publ)
2.2285 of 5 stars		$18.40
+1.8%		$34.00
+84.8%		-17.6%$548.14M$113.78M-11.22192Short Interest ↑
ALT
Altimmune
1.357 of 5 stars		$7.57
+1.3%		$15.00
+98.2%		+46.4%$536.64M$430,000.00-4.5959Short Interest ↑

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NASDAQ:ZJYL) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
He Is Giving Away Bitcoin
Crypto Swap Profits
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
Why Big Pharma is Investing Billions in This Biotech
Behind the Markets